DT
HealthMore in Health→
Semaglutide study links diabetes drug to improved motivation in major depressive disorder
Key Takeaways
- A study published in JAMA Psychiatry found semaglutide significantly improved measures of motivation in patients with major depressive disorder.
- The reported effect focuses on motivation, a clinically important symptom domain in depression.
- The supplied source does not provide trial size, effect size, or treatment protocol details, so the finding remains an early but notable signal.
DE
DT Editorial Team··via medicalxpress.com
